Overview

Vaginal DHEA for Women After Breast Cancer

Status:
Withdrawn
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
There does not appear to be a consensus regarding the treatment of vaginal dryness in women who have a contraindication to the use of estrogen products. DHEA, when used locally, may improve the symptoms of vaginal dryness due to its chemical properties.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Hadassah Medical Organization
Treatments:
Dehydroepiandrosterone